fda enforcement actions bpc-157 Before the FDA: Briefing Document Focuses on… FDA's Overreach on Compounded Peptides

In UK clinical settings, the recognised standard diluent for injectable medicines is Water for Injections BP (single-use, preservative-free), and the choice of diluent must always follow the licensed product's Summary of Product Characteristics (SmPC)

It increases blood vessel growth (a process called collateralization) and increases the activity of fibroblasts, the cells that build and repair connective tissue

Still experimental but widely circulating in grey markets across different countries

This is particularly meaningful from a research perspective, as elevated triglycerides represent an independent cardiovascular risk factor that is often undertreated by GLP-1 class compounds alone